SOMATIC CELL REPROGRAMMING
    2.
    发明申请

    公开(公告)号:US20200239840A1

    公开(公告)日:2020-07-30

    申请号:US16818958

    申请日:2020-03-13

    Abstract: The present invention relates to methods for reprogramming a somatic cell to pluripotency by administering into the somatic cell at least one or a plurality of potency-determining factors. The invention also relates to pluripotent cell populations obtained using a reprogramming method.

    SOMATIC CELL REPROGRAMMING
    4.
    发明申请

    公开(公告)号:US20190106675A1

    公开(公告)日:2019-04-11

    申请号:US16137899

    申请日:2018-09-21

    Abstract: The present invention relates to methods for reprogramming a somatic cell to pluripotency by administering into the somatic cell at least one or a plurality of potency-determining factors. The invention also relates to pluripotent cell populations obtained using a reprogramming method.

Patent Agency Ranking